Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004363:Drug Utilization / Q000639:trends; D006760:Hospitalization; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D009566:Nitrates / Q000627:therapeutic use; D012955:Societies, Medical; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014481:United States
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D004071:Digitalis Glycosides; D009566:Nitrates; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone